Document is current
Any future updates will be listed below
-
Authors
Gyrd-Hansen, Mads https://orcid.org/0000-0001-5641-5019
Kajaste-Rudnitski, Anna
Manel, Nicolas https://orcid.org/0000-0002-1481-4430
Rehwinkel, Jan https://orcid.org/0000-0003-3841-835X
van der Veen, Annemarthe G. https://orcid.org/0000-0001-9324-3404
Iannacone, Matteo https://orcid.org/0000-0002-9370-2671
- License Information
-
More Information
Article History
First Online: 15 July 2024
Competing interests
: M.I. participates in advisory boards/consultantship for Asher Biotherapeutics, GentiBio, BlueJay Therapeutics and Aligos Therapeutics and receives funding from Gilead Sciences and VIR Biotechnology. All other authors have no competing interests.
